ABILIFY MAINTENA depot 400 mg seringue préremplie

7680657740011 CH-65774 N05AX12 01.05.0.
ABILIFY MAINTENA depot 400 mg seringue préremplie
ABILIFY MAINTENA depot 400 mg seringue préremplie
ABILIFY MAINTENA depot 400 mg seringue préremplie
1 / 3
google

Details

Product number
6577401
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
Praeparatio cryodesiccata: aripiprazolum 400 mg ut aripiprazolum monohydricum, carmellosum natricum, mannitolum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, ad pulverem. Solvens: aqua ad iniectabile. Solutio reconstituta: aripiprazolum 400 mg ut aripiprazolum monohydricum, carmellosum natricum, mannitolum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium max. 2.2 mg.

Articles (1)

Abilify Maintena 400 mg, Depot-Injektionssuspension in einer Fertigspritze
Injektionssuspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
05/02/2024
Professional SmPC
Français
05/02/2024
Professional SmPC
Italien
05/02/2024

Detailed composition

Substance Quantity Type Category
PRC
400.0 MG Substance Wirkstoff (Principe actif)
SOLR
400.0 MG Substance Wirkstoff (Principe actif)
SOLV
- Substance HNIDK
PRC
- Substance WIZUS
SOLR
- Substance WIZUS
PRC
- Substance HNIDK
SOLR
- Substance HNIDK
PRC
- Substance HNIDK
SOLR
- Substance HNIDK
SOLR
- Substance HNIDK
PRC
- Substance HNIDK
SOLR
- Substance HNIDK
PRC
- Substance HNIDK
SOLR
- Substance HNIDK
SOLR
- Substance HBESI

Reimbursement information

Public price
CHF 311.95
Specialties list
Yes
Generic
No
SL addition date: 01/05/2016

Authorization holder

Lundbeck (Schweiz) AG

8152 Opfikon

Authorization information

Swissmedic authorization number
65774
Drug name
Abilify Maintena, Depot-Injektionssuspension in einer Fertigspritze
Galenic form
PULP
ATC Code
N05AX12
Authorization status
Z
Dispensation category
B
First authorization
15/03/2016
Authorization expiration date
31/12/9999
IT number
01.05.0.
Domain
Human medicine
Field of application
Neuroleptikum

Packaging details

Description (FR)
ABILIFY MAINTENA depot 400 mg seringue préremplie
Description (DE)
ABILIFY MAINTENA Depot 400 mg Fertigspritze
Market launch
15/03/2016
Narcotic (BTM)
No

Available generics

Aripiprazol-Mepha oro, Schmelztabletten
CHF 66.80
View
Aripiprazol-Mepha oro, Schmelztabletten
CHF 72.40
View
Aripiprazol-Mepha, Tabletten
CHF 62.65
View
Aripiprazol-Mepha, Tabletten
CHF 151.35
View
Aripiprazol-Mepha, Tabletten
CHF 66.80
View
Aripiprazol-Mepha, Tabletten
CHF 163.30
View
Aripiprazol-Mepha, Tabletten
CHF 72.40
View
Aripiprazol-Mepha, Tabletten
CHF 179.60
View
Aripiprazol-Mepha, Tabletten
CHF 117.10
View
Aripiprazol-Mepha, Tabletten
CHF 310.10
View

Other packaging sizes